TENB2, also known as tomoregulin or transmembrane protein with epidermal growth factor (EGF)-like and two follistatin-like domains (TMEFF), is a proteoglycan over-expressed in human prostate tumors [7], and has been pursued as an ADC target [8, 9]. Here, EGF is linked to prostate neoplasm.